E3 PreliminaryPreliminaryPEM unclearCase-ControlPeer-reviewedMachine draft
Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome.
Goertzel, Benjamin N, Pennachin, Cassio, de Souza Coelho, Lucio et al. · Pharmacogenomics · 2006 · DOI
Quick Summary
Researchers looked at genetic variations (called SNPs) in genes related to stress hormones and brain chemistry to see if they could predict who has ME/CFS. Using patterns from 28 specific genetic variants, they correctly identified ME/CFS in about 76% of patients tested. This suggests that genetics play a role in ME/CFS, though genes are not the whole story.
Why It Matters
This study provides evidence that ME/CFS has a measurable genetic component, which may help explain why some people develop the illness and others do not. Understanding genetic risk factors could eventually lead to better diagnostic tests and personalized treatments tailored to a patient's genetic profile.
Observed Findings
- A combination of 28 SNPs predicted ME/CFS status with 76.3% accuracy in the study sample.
- The three genes most frequently involved in accurate predictions were TPH2 (serotonin synthesis), COMT (dopamine and norepinephrine metabolism), and NR3C1 (glucocorticoid receptor).
- Combined SNP patterns predicted CFS more accurately than analyzing individual SNPs in isolation.
- The predictive model generated 28 true positives, 49 true negatives, 15 false negatives, and 9 false positives.
Inferred Conclusions
- ME/CFS has a heritable genetic component that contributes to disease susceptibility.
- Gene-gene interactions (epistasis) in neuroendocrine and neurotransmitter systems may be more informative than single-gene associations for predicting CFS.
- Genetic profiling may eventually assist in diagnosing ME/CFS or identifying at-risk individuals.
Remaining Questions
- Does the predictive SNP ensemble replicate in larger, independent patient populations?
- What is the mechanistic relationship between these genetic variants and the pathophysiology of ME/CFS?
- How do these genetic factors interact with environmental triggers, infections, or other non-genetic risk factors?
What This Study Does Not Prove
This study does not prove that genes *cause* ME/CFS—only that certain genetic patterns are associated with the illness. The 76% accuracy means genetic factors alone cannot fully predict who has ME/CFS; environmental triggers, infections, and other factors also play important roles. Results need replication in larger, independent populations before being used clinically.
Tags
Symptom:Fatigue
Biomarker:Gene Expression
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.2217/14622416.7.3.475
- PMID
- 16610957
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →